HC Wainwright & Co. Maintains Buy on PepGen, Lowers Price Target to $14

Benzinga · 05/09 13:29
HC Wainwright & Co. analyst Andrew Fein maintains PepGen (NASDAQ:PEPG) with a Buy and lowers the price target from $16 to $14.